The influence of upper abdominal surgery on perioperative morbidity and mortality in patients with advanced ovarian cancer FIGO III and FIGO IV

International Journal of Gynecological Cancer

Volumn 8, Issue 1, 1998, Pages 56-63

  Kuhn, W ^a   Florack, G ^a   Roder, J ^a   Schmalfeldt, B ^a   Pache, L ^a   Rust, M ^a   Ulm, K ^a   Spathe K ^a   Janicke F ^b   Siewert, J Rüdiger ^a   Graeff, H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Morbidity; Ovarian cancer; Survival; Upper abdominal surgery

Indexed keywords

ABDOMINAL CANCER; ADULT; ADVANCED CANCER; ARTICLE; CHOLECYSTECTOMY; CLINICAL ARTICLE; FEMALE; HUMAN; INTENSIVE CARE; MORBIDITY; MORTALITY; OVARY CANCER; PANCREAS RESECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SPLENECTOMY;

EID: 0031886357     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. FIGO Cancer Committee. Staging announcement. Gynecol Oncol 1986; 25: 383.
2. Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Elashoff RM. Primary cytoreductive surgery for epithelial ovarian cancer. Obstet Gynecol 1983; 61: 413-20.
3. Heintz APM, Hacker NF, Berek JS, Rose TP, Munoz AK, Lagasse LD. Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity. Obstet Gynecol 1986; 67: 783-8.
4. Jänicke F, Hälscher M, Kuhn W, von Hugo R, Pache L, Siewert JR et al. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer 1992; 70: 2129-36.
5. Kuhn W, Jänicke F, Pache L, Hölscher M, Schattenmann G, Schmalfeldt B et al. Entwicklungen in der Therapie des fortgeschrittenen Ovarialkarzinoms FIGO III. Geburtsh u Frauenheilk 1993; 53: 293-302.
6. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY et al. Cyclophosphamide and Cisplatin compared with Paclitaxel and Cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334: 1-6.
7. Soper JT, Couchman G, Berchuck A, Clarke-Pearson D. The role of partial sigmoid colectomy for debulking epithelial ovarian carcinoma. Gynecol Oncol 1991; 41: 239-44.
8. Miholic J, Kölbl H, Hanzal E, Gitsch G, Schemper M, Moeschl P et al. Die Rolle von Darmresektionen bei der Erstoperation des Ovarialkarzinoms. Zentralbl Chir 1991; 116: 465-70.
9. Scarabelli C, Gallo A, Zarrelli A, Visentin C, Campagnutta A. Systematic pelvic and para-aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival. Gynecol Oncol 1995; 56: 328-37.
10. Burghardt E, Pickel H, Lahousen M, Stettner H. Pelvic lymphadenectomy in operative treatment of ovarian cancer. Am J Obstet Gynecol 1986; 155: 315-9.
11. Hacker NF. Systematic pelvic and para-aortic lymphadenectomy for advanced ovarian cancer-therapeutic advance or surgical folly? Editorial. Gynecol Oncol 1995; 56: 325-7.
12. Montz FJ, Schlaerth JB, Berek JS. Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer. Gynecol Oncol 1989; 35: 338-40.
13. Fiorica JV, Hoffman MS, LaPolla JP, Roberts WS, Cavanagh D. The management of diaphragmatic lesions in ovarian carcinoma. Obstet Gynecol 1989; 74: 927-9.
14. Sonnendecker EWW, Guidozzi F, Margolius KA. Splenectomy during primary maximal cytoreductive surgery for epithelial ovarian cancer. Gynecol Oncol 1989; 35: 301-6.
15. Deppe G, Zbella EA, Skogerson K, Dumitru I. The rare indication for splenectomy as part of cytoreductive surgery in ovarian cancer. Gynecol Oncol 1983; 16: 282-7.
16. Sevin B-U, Graeff H. Prinzip der Staging-Laparotomie beim Ovarialcarcinom. Chirurg 1994; 65: 2-9.
17. Jänicke F, Schattenmann G, Kuhn W, Graeff H, Siewert JR. Sekundäre Debulking-Operation beim Ovarialcarcinom. Chirurg 1994; 65: 10-7.